{"id":"fms-placebo-tablets","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo tablets are inert formulations used as control comparators in clinical trials or, in some cases, as marketed products where the therapeutic benefit derives from patient expectation and the placebo effect rather than pharmacological action. FMS placebo tablets from the University of Taubate appear to be a marketed placebo product, likely used in research or clinical settings.","oneSentence":"A placebo tablet that contains no active pharmaceutical ingredient and produces therapeutic effects through the placebo effect mechanism.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:30:13.656Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06752590","phase":"PHASE2","title":"A Clinical Study of ONO-1110 in Patients With Fibromyalgia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ono Pharmaceutical Co. Ltd","startDate":"2025-03-26","conditions":"Fibromyalgia","enrollment":160},{"nctId":"NCT04107727","phase":"PHASE2","title":"Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"PETHEMA Foundation","startDate":"2019-09-05","conditions":"Acute Myeloid Leukemia","enrollment":273},{"nctId":"NCT07398417","phase":"PHASE3","title":"Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design","status":"RECRUITING","sponsor":"Axsome Therapeutics, Inc.","startDate":"2026-01-14","conditions":"Fibromyalgia","enrollment":620},{"nctId":"NCT05395494","phase":"PHASE2","title":"iTBS-DCS in Fibromyalgia","status":"TERMINATED","sponsor":"University of Calgary","startDate":"2022-08-29","conditions":"Fibromyalgia","enrollment":47},{"nctId":"NCT05900466","phase":"PHASE2","title":"Metformin for Fibromyalgia Symptoms (INFORM Trial)","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-04-01","conditions":"Fibromyalgia Syndrome","enrollment":72},{"nctId":"NCT02829814","phase":"PHASE3","title":"Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia","status":"TERMINATED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2016-07-22","conditions":"Fibromyalgia, Myofascial Pain Syndromes, Muscular Diseases","enrollment":51},{"nctId":"NCT04238364","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers","status":"COMPLETED","sponsor":"Elixiron Immunotherapeutics (Hong Kong) Ltd.","startDate":"2019-12-27","conditions":"Healthy Volunteers","enrollment":58},{"nctId":"NCT02436096","phase":"PHASE3","title":"A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2015-04","conditions":"Fibromyalgia, Myofascial Pain Syndromes, Muscular Diseases","enrollment":519},{"nctId":"NCT05273749","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With Fibromyalgia","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2022-04-06","conditions":"Fibromyalgia","enrollment":457},{"nctId":"NCT02997202","phase":"PHASE3","title":"A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2017-08-16","conditions":"Acute Myeloid Leukemia","enrollment":356},{"nctId":"NCT02927262","phase":"PHASE2","title":"A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2017-01-10","conditions":"Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation","enrollment":98},{"nctId":"NCT04739995","phase":"PHASE4","title":"Cost-utility and Physiological Effects of LDN in Patients With Fibromyalgia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundació Sant Joan de Déu","startDate":"2022-06-01","conditions":"Randomized Controlled Trial","enrollment":99},{"nctId":"NCT04729179","phase":"PHASE3","title":"Cannabidiol for Fibromyalgia (The CANNFIB Trial)","status":"COMPLETED","sponsor":"Marius Henriksen","startDate":"2021-03-01","conditions":"Fibromyalgia","enrollment":200},{"nctId":"NCT02806440","phase":"PHASE4","title":"Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2016-06","conditions":"Fibromyalgia","enrollment":58},{"nctId":"NCT04508621","phase":"PHASE3","title":"A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2020-07-22","conditions":"Fibromyalgia","enrollment":514},{"nctId":"NCT05933486","phase":"PHASE4","title":"Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome","status":"UNKNOWN","sponsor":"Quan Jiang","startDate":"2023-09","conditions":"Fibromyalgia Syndrome","enrollment":150},{"nctId":"NCT05389761","phase":"NA","title":"Fibromyalgia Treatment With Enzyme DAO","status":"COMPLETED","sponsor":"Centros de Investigación de Nutrición y Salud","startDate":"2022-02-22","conditions":"Fibromyalgia","enrollment":100},{"nctId":"NCT05605886","phase":"EARLY_PHASE1","title":"Botulinum Toxin A in Patients With Myofascial Pain Syndrome With and Without Zinc Supplementation","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-05-20","conditions":"Myofacial Pain Syndrome, Botulinum Toxin","enrollment":24},{"nctId":"NCT04270877","phase":"PHASE2","title":"Fibromyalgia and Naltrexone: The FINAL Study","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2021-01-06","conditions":"Fibromyalgia","enrollment":99},{"nctId":"NCT04748705","phase":"PHASE2","title":"Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1","status":"COMPLETED","sponsor":"Virios Therapeutics, Inc.","startDate":"2021-06-03","conditions":"Fibromyalgia","enrollment":422},{"nctId":"NCT04172831","phase":"PHASE3","title":"A Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2019-12-09","conditions":"Fibromyalgia","enrollment":503},{"nctId":"NCT05050656","phase":"PHASE4","title":"Oral Duloxetine as a Premedication for Postoperative Pain Control","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-03-15","conditions":"Anesthesia","enrollment":70},{"nctId":"NCT01271933","phase":"PHASE3","title":"Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-03","conditions":"Fibromyalgia","enrollment":441},{"nctId":"NCT02496884","phase":"PHASE3","title":"Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2015-06-26","conditions":"Fibromyalgia","enrollment":56},{"nctId":"NCT02187471","phase":"PHASE3","title":"Treatment of Pain Associated With Fibromyalgia","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2015-01-16","conditions":"Pain Associated With Fibromyalgia","enrollment":1301},{"nctId":"NCT02187159","phase":"PHASE3","title":"Treatment of Pain Associated With Fibromyalgia","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2014-11","conditions":"Pain Associated With Fibromyalgia","enrollment":1270},{"nctId":"NCT02146430","phase":"PHASE3","title":"Treatment of Pain Associated With Fibromyalgia","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2014-10-27","conditions":"Pain Associated With Fibromyalgia","enrollment":1293},{"nctId":"NCT01732718","phase":"PHASE2","title":"Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2013-09","conditions":"Sickle Cell Disease, Sickle Cell Nephropathy","enrollment":13},{"nctId":"NCT00612170","phase":"PHASE3","title":"A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-12","conditions":"Fibromyalgia","enrollment":1129},{"nctId":"NCT00810368","phase":"PHASE2","title":"Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2008-08","conditions":"Persian Gulf Syndrome","enrollment":33},{"nctId":"NCT01598753","phase":"PHASE3","title":"Combined Behavioral and Analgesic Trial for Fibromyalgia","status":"COMPLETED","sponsor":"University of Washington","startDate":"2012-05","conditions":"Fibromyalgia","enrollment":134},{"nctId":"NCT01328002","phase":"PHASE2","title":"Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia","status":"TERMINATED","sponsor":"Forest Laboratories","startDate":"2011-04-30","conditions":"Primary Fibromyalgia","enrollment":116},{"nctId":"NCT03717740","phase":"PHASE3","title":"Esomeprazole for the Prevention of Preeclampsia","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2018-12-01","conditions":"Pre-Eclampsia","enrollment":1000},{"nctId":"NCT03783910","phase":"PHASE2","title":"Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2005-09-19","conditions":"Primary Fibromyalgia","enrollment":90},{"nctId":"NCT00752505","phase":"PHASE2","title":"A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-08","conditions":"Fibromyalgia","enrollment":89},{"nctId":"NCT00796601","phase":"PHASE3","title":"Maintenance of Efficacy.","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2009-05-01","conditions":"Fibromyalgia","enrollment":""},{"nctId":"NCT03058224","phase":"NA","title":"Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia","status":"COMPLETED","sponsor":"IgNova GmbH","startDate":"2017-02-16","conditions":"Chronic Widespread Pain, Fibromyalgia","enrollment":230},{"nctId":"NCT00401830","phase":"PHASE2","title":"Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-10","conditions":"Fibromyalgia Syndrome","enrollment":159},{"nctId":"NCT01820052","phase":"PHASE3","title":"A Randomized Trial of Oral Iron Therapy in Fibromyalgia","status":"COMPLETED","sponsor":"Sanjay Gandhi Postgraduate Institute of Medical Sciences","startDate":"2013-04","conditions":"Primary Fibromyalgia","enrollment":120},{"nctId":"NCT01173055","phase":"PHASE4","title":"A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2010-06","conditions":"Fibromyalgia","enrollment":22},{"nctId":"NCT00719537","phase":"NA","title":"Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia","status":"TERMINATED","sponsor":"John Uckele","startDate":"2008-07","conditions":"Preeclampsia","enrollment":3},{"nctId":"NCT01903265","phase":"PHASE2, PHASE3","title":"BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)","status":"COMPLETED","sponsor":"Tonix Pharmaceuticals, Inc.","startDate":"2013-09","conditions":"Primary Fibromyalgia","enrollment":205},{"nctId":"NCT02868814","phase":"PHASE3","title":"The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2016-05","conditions":"Fibromyalgia","enrollment":240},{"nctId":"NCT01359826","phase":"PHASE4","title":"The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients","status":"WITHDRAWN","sponsor":"Loma Linda University","startDate":"2011-10","conditions":"Systemic Lupus Erythematosus, Widespread Pain, Fibromyalgia","enrollment":""},{"nctId":"NCT02215460","phase":"PHASE4","title":"Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours","status":"COMPLETED","sponsor":"University of Taubate","startDate":"2012-04","conditions":"Periodontitis","enrollment":130},{"nctId":"NCT01458964","phase":"PHASE4","title":"Quetiapine Compared With Placebo in the Management of Fibromyalgia","status":"COMPLETED","sponsor":"East Tennessee State University","startDate":"2008-01","conditions":"Fibromyalgia","enrollment":42},{"nctId":"NCT00689052","phase":"PHASE2","title":"Pramipexole ER vs. Placebo in Fibromyalgia","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2008-07","conditions":"Fibromyalgia","enrollment":61},{"nctId":"NCT01820585","phase":"PHASE2","title":"Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2009-04","conditions":"Fibromyalgia","enrollment":528},{"nctId":"NCT00254657","phase":"NA","title":"Levetiracetam for Treatment of Pain Associated With Fibromyalgia","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2004-03","conditions":"Fibromyalgia","enrollment":66},{"nctId":"NCT01653457","phase":"PHASE3","title":"Randomised Controlled Trial of Memantine in Fibromyalgia","status":"UNKNOWN","sponsor":"Aragon Institute of Health Sciences","startDate":"2012-09","conditions":"Fibromyalgia","enrollment":60},{"nctId":"NCT00919295","phase":"PHASE2","title":"Study of Indoleamine 2,3-dioxygenase Activity, Serum Levels of Cytokines, BDNF, BH4 and Mirtazapine Efficacy in Fibromyalgia Syndrome","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2008-12","conditions":"Fibromyalgia Syndrome","enrollment":80},{"nctId":"NCT00369343","phase":"PHASE3","title":"Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-09","conditions":"Depression, Depressive Disorder, Depressive Disorder, Major","enrollment":381},{"nctId":"NCT01077375","phase":"PHASE4","title":"Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2010-02","conditions":"Fibromyalgia","enrollment":107},{"nctId":"NCT01014585","phase":"PHASE4","title":"Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2009-11","conditions":"Fibromyalgia","enrollment":340},{"nctId":"NCT00803023","phase":"PHASE3","title":"Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2010-03","conditions":"Fibromyalgia","enrollment":129},{"nctId":"NCT00675896","phase":"PHASE4","title":"A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome","status":"COMPLETED","sponsor":"Dr Alexander McIntyre Inc.","startDate":"2007-04","conditions":"Major Depression","enrollment":120},{"nctId":"NCT00618956","phase":"PHASE3","title":"A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2007-10","conditions":"Fibromyalgia","enrollment":321},{"nctId":"NCT00528710","phase":"PHASE2","title":"Efficacy of S-Adenosylmethionine in Fibromyalgia","status":"COMPLETED","sponsor":"Deakin University","startDate":"2006-11","conditions":"Fibromyalgia Syndrome","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"FMS placebo tablets","genericName":"FMS placebo tablets","companyName":"University of Taubate","companyId":"university-of-taubate","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}